Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2

European Journal of Immunology
A EgleR Greil

Abstract

The Apo-1/Fas (CD95) antigen is known to be involved in the process of T cell-mediated target cell killing and has recently been shown to be expressed on myeloma cell lines and native malignant plasma cells. Several cytokines have been reported to interfere with spontaneous and even Apo-1/Fas-induced apoptosis, but no attempt has been made yet to investigate these interactions and the possible underlying mechanisms in myeloma cells. Since in myeloma patients Interferon (IFN)-alpha2 displays a profound therapeutic effect in vivo, which is usually attributed to its growth inhibitory and/or immunomodulatory capacity, we set out to study the potential interference of IFN-alpha2 with Apo-1/Fas-induced apoptosis. Contrary to expectations, IFN-alpha2 reduced the degree of apoptosis caused by the treatment of five Apo-1/Fas-sensitive myeloma cell lines with a Fas monoclonal antibody (mAb). Simultaneous application of IFN-alpha2 and Fas mAb was superior to the prolonged (i.e. >8 h) preincubation with the cytokine as far as inhibition of Apo-1/Fas-induced apoptosis was concerned. This effect of IFN-alpha2 was neither explained by a down-regulation of the Apo-1/Fas receptor nor caused by modulation of the expression levels of c-myc, bcl-2...Continue Reading

References

Apr 3, 1992·Cell·G I EvanD C Hancock
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H LudwigH L Seewann
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N C Reich, L M Pfeffer
Feb 1, 1986·Analytical Biochemistry·H J BurtscherM Hirsch-Kauffmann
Feb 15, 1983·International Journal of Cancer. Journal International Du Cancer·R E RittsB L Strehlo
Mar 10, 1995·Science·S Nagata, P Golstein
Jan 1, 1995·Journal of Cellular Biochemistry·D FindikM Lavin
Jun 1, 1995·Molecular and Cellular Biology·L B Owen-SchaubE Kruzel
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·C G TepperM F Seldin
Mar 29, 1995·International Journal of Cancer. Journal International Du Cancer·J Rodríguez-Villanueva, T J McDonnell
Jan 1, 1994·The Journal of Clinical Investigation·Y Levy, J C Brouet
Oct 1, 1995·Current Opinion in Immunology·D R Green, S J Martin
Feb 8, 1996·International Journal of Cancer. Journal International Du Cancer·A VillungerR Greil

❮ Previous
Next ❯

Citations

Jul 22, 1998·Journal of Neuroimmunology·W RothM Weller
Apr 8, 1998·International Journal of Radiation Oncology, Biology, Physics·M P FuggettaE Bonmassar
Jun 9, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·C L Davis
Nov 20, 1998·Clinical and Experimental Immunology·M A FrassanitoF Dammacco
Oct 8, 1999·The New England Journal of Medicine·H U SimonK Blaser
Aug 3, 1999·The Journal of Experimental Medicine·L GabrieleH C Morse
Jul 16, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Michael J Clemens
Jun 27, 1998·Leukemia & Lymphoma·R G Hawley, L C Berger
Feb 20, 2007·Molecular Aspects of Medicine·Sonia MinuzzoAlberto Amadori
Nov 26, 2009·The Journal of International Medical Research·Andrej PlesnicarB Kores Plesnicar
Jun 1, 1997·European Journal of Immunology·M C Ruiz-RuizA López-Rivas
Nov 18, 2004·Immunological Reviews·Mark J SmythYoshihiro Hayakawa
Mar 26, 1999·European Journal of Immunology·D PillingM Salmon
Jan 16, 2003·Seminars in Arthritis and Rheumatism·Leslie E WilsonPeter D Gorevic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.